Evidence map›Paper›PMID 29555943›Full record

ArticleScientific reports2018

Dynamic metabolic patterns tracking neurodegeneration and gliosis following 26S proteasome dysfunction in mouse forebrain neurons.

Philippine C Geiszler, Aslihan Ugun-Klusek, Karen Lawler, Marie-Christine Pardon, Ding Yuchun, Li Bai, Clare A Daykin, Dorothee P Auer, Lynn Bedford

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Philippine C GeiszlerDivision of Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, UK.
Aslihan Ugun-KlusekSchool of Science and Technology, Nottingham Trent University, Nottingham, UK.
Karen LawlerSchool of Life Sciences, University of Nottingham, Nottingham, UK.
Marie-Christine PardonSchool of Life Sciences, University of Nottingham, Nottingham, UK.
Ding YuchunSchool of Computing, University of Newcastle, Newcastle, UK.
Li BaiSchool of Computer Sciences, University of Nottingham, Nottingham, UK.
Clare A DaykinSchool of Pharmacy, University of Nottingham, Nottingham, UK.
Dorothee P AuerDivision of Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, UK. dorothee.auer@nottingham.ac.uk.
Lynn BedfordSchool of Life Sciences, University of Nottingham, Nottingham, UK. lynn.bedford@nottingham.ac.uk.
University of Nottingham · GBNewcastle University · GBNottingham Trent University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolite profiling is an important tool that may better capture the multiple features of neurodegeneration. With the considerable parallels between mouse and human metabolism, the use of metabolomics in mouse models with neurodegenerative pathology provides mechanistic insight and ready translation into aspects of human disease. Using 400 MHz nuclear magnetic resonance spectroscopy we have carried out a temporal region-specific investigation of the metabolome of neuron-specific 26S proteasome knockout mice characterised by progressive neurodegeneration and Lewy-like inclusion formation in the forebrain. An early significant decrease in N-acetyl aspartate revealed evidence of neuronal dysfunction before cell death that may be associated with changes in brain neuroenergetics, underpinning the use of this metabolite to track neuronal health. Importantly, we show early and extensive activation of astrocytes and microglia in response to targeted neuronal dysfunction in this context, but only late changes in myo-inositol; the best established glial cell marker in magnetic resonance spectroscopy studies, supporting recent evidence that additional early neuroinflammatory markers are needed. Our results extend the limited understanding of metabolite changes associated with gliosis and provide evidence that changes in glutamate homeostasis and lactate may correlate with astrocyte activation and have biomarker potential for tracking neuroinflammation.

Indexed as

MetabolomicsAnimalsGliosisMiceNeuronsProsencephalonProteasome Endopeptidase ComplexATP dependent 26S proteaseProteasome Endopeptidase Complex

Identifiers

PMID29555943
PMCPMC5859111
OpenAlexW2790322962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.